| 000 | 01390 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515210658.0 | ||
| 264 | 0 | _c20100430 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a0301-1526 | ||
| 024 | 7 |
_a10.1024/0301-1526/a000012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLinnemann, B | |
| 245 | 0 | 0 |
_aAlteration of pharmacokinetics of lepirudin caused by anti-lepirudin antibodies occurring after long-term subcutaneous treatment in a patient with recurrent VTE due to Behcets disease. _h[electronic resource] |
| 260 |
_bVASA. Zeitschrift fur Gefasskrankheiten _cFeb 2010 |
||
| 300 |
_a103-7 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aBehcet Syndrome _xcomplications |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xtherapeutic use |
| 650 | 0 | 4 |
_aHirudins _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aVenous Thromboembolism _xdrug therapy |
| 700 | 1 | _aGreinacher, A | |
| 700 | 1 | _aLindhoff-Last, E | |
| 773 | 0 |
_tVASA. Zeitschrift fur Gefasskrankheiten _gvol. 39 _gno. 1 _gp. 103-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1024/0301-1526/a000012 _zAvailable from publisher's website |
| 999 |
_c19554932 _d19554932 |
||